Neuberger Berman Group LLC Ocugen, Inc. Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 10,744 shares of OCGN stock, worth $15,901. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,744
Previous 10,744
-0.0%
Holding current value
$15,901
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
108Shares Held
64.3MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$26.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$21.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$7.49 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$6.15 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$5.16 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $321M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...